Reset with Lynlee

On the Soul of Business, Claressa Monteiro speaks to Dr Jennifer Bourland, Head of Innovation Domain Cell & Tissue Systems, Evonik and Dr. Massimo Alberti, CEO and Founder, Revivo, on their partnership to develop organ-on-a-chip technology that will revolutionise chemical testing and drug development. 

See omnystudio.com/listener for privacy information.

On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.

See omnystudio.com/listener for privacy information.

The buzz in 2022 is on Temasek’s Vertex Venture Holdings and Tikehau Capital SCA-backed Pegasus with both set to kick a first wave of SPAC listing on the Singapore Stock Exchange this week and next week. On Market View, Claressa Monteiro is joined by Emelia Tan, Research Analyst with the SGX as they deep dive into what is a SPAC company? Are there risks involved and if there are, are there any safeguards for investors? 

See omnystudio.com/listener for privacy information.

On Health Suites, Claressa Monteiro speaks to Professor Michael Young, 2017 Nobel Prize recipient for Physiology or Medicine. She learns more about his current research of fruit flies and the potential correlation to pathological consequences in humans.

See omnystudio.com/listener for privacy information.

On Health Suites, Claressa Monteiro speaks to Dr Robert Langer, Co-Founder Moderna Inc, to find out more about the man and the science that drives him. 

See omnystudio.com/listener for privacy information.